Colorectal most cancers (CRC) is the third most identified most cancers worldwide. Progesterone is related to a decreased danger of CRC and results in a beneficial prognosis. Nonetheless, the precise mechanism by which progesterone suppresses malignant development stays to be elucidated. Within the current research, the extent of progesterone was first analysed in 77 sufferers with CRC, and immunohistochemistry was carried out to detect the expression of progesterone receptor (PGR) within the paired specimens. The correlations between progesterone, PGR and CRC prognosis had been assessed. A Cell Counting Package‑eight assay was then used to detect proliferation of the CRC cells. Circulation cytometry was carried out to estimate apoptosis and to guage the cycle of the CRC cells.
A xenograft tumour mannequin was established in nude mice to evaluate the function of progesterone in tumour development. Lastly, a PCR microarray was used to display screen differentially expressed genes to additional interpret the mechanism by which progesterone inhibits the malignant development of CRC. It was discovered that low expression of progesterone and PGR had been considerably related to poor prognosis of CRC. As well as, progesterone suppressed CRC cell proliferation by arresting the cell cycle and inducing apoptosis in vitro. Furthermore, the inhibitory function of progesterone in tumour development was verified in vivo.
Additional investigation confirmed that the extent of development arrest and DNA harm‑inducible protein α (GADD45α) was up‑regulated by progesterone, and this was adopted by the activation of the JNK pathway. Progesterone elevated the exercise of the JNK pathway through GADD45α to inhibit proliferation by arresting the cell cycle and inducing apoptosis, thereby suppressing the malignant development of CRC. Subsequently, it may be concluded that progesterone and PGR may act as inhibiting elements for poor prognosis of CRC.
Decide the incremental yield of subsequent technology sequencing (predominantly exome sequencing (ES)) over quantitative fluorescence-polymerase chain response (QF-PCR) and chromosome microarray evaluation (CMA)/karyotyping in; (i) all instances of prenatally identified non-immune hydrops fetalis (NIHF); (ii) remoted NIHF; (iii) NIHF related to further structural anomalies and; (iv) NIHF in line with severity (i.e., two cavities versus three or extra cavities affected).
MiRNA expression profiling and emergence of latest prognostic signature for oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC), the commonest sort of head and neck cancers, is related to excessive recurrence, metastasis, low long-term survival charges and poor remedy consequence. As deregulated miRNA expression performs an important function in malignant transformation and most cancers development, the current research is aimed toward profiling the miRNA expression sample in OSCC and creating a brand new miRNA prognostic signature for oral most cancers. MiRNA expression profiling was carried out utilizing MiRNA microarray in 30 tumor and 18 regular samples. MiRNA signature obtained was validated with quantitative actual time PCR (qRT-PCR) in 144 tumor and 36 regular samples.
The potential targets, scientific implications and prognostic worth of the miRNA signature had been elucidated by numerous bioinformatics and statistical analyses. Microarray profiling recognized a set of 105 miRNAs to be differentially expressed in OSCC, out of which a subset of 19 most dysregulated miRNAs had been validated by qRT-PCR. In silico evaluation revealed the signature miRNAs to be concerned in numerous most cancers related pathways. Up-regulation of miR-196a, miR-21, miR-1237 and downregulation of miR-204, miR-144 was related to poor prognosis of OSCC sufferers. The mir-196a/miR-204 expression ratio emerged as finest predictor for illness recurrence and affected person survival. Altogether, our research recognized a miRNA signature for OSCC with prognostic significance.
Identification of fibroblast activation-related genes in two acute kidney harm fashions
Ischemia-reperfusion harm and drug-induced nephrotoxicity are the 2 most typical causes for acute kidney harm (AKI). Nonetheless, little consideration has been paid to early activation of fibroblasts within the development of AKI to persistent kidney illness (CKD). The current research aimed to determine associated genes and pathways on fibroblast activation in two mouse fashions of AKI: ischemia-reperfusion harm (IRI) mannequin and folic acid (FA)-induced harm mannequin. The microarray expression profiles of GSE62732 and GSE121190 had been downloaded from the GEO database, and the differentially expressed genes (DEGs) was analyzed utilizing the Limma bundle of R software program.
Principal element evaluation (PCA) was additionally carried out utilizing R. The practical info of gene merchandise was annotated by Gene Ontology (GO) and DAVID on-line database, and the pathway evaluation was carried out through the use of the Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) database. Protein-protein interactions (PPI) community was constructed by STRING and Cytoscape. Moreover, within the Hypoxia/Reoxygenation (H/R) mannequin, the morphological adjustments of cells had been noticed beneath microscope and the expression of the hub genes in NRK-49F cells had been validated by qRT-PCR assays. A complete of 457 DEGs had been recognized.
 25 mm Diameter Tapped Titanium Tip |
|
0-120-0014 |
Biologics |
25 mm |
EUR 682 |
 25 mm Diameter Solid Titanium Tip |
|
0-120-0015 |
Biologics |
25 mm |
EUR 614 |
 Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|
0-120-0016 |
Biologics |
13 mm |
EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
 Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|
0-120-0017 |
Biologics |
19 mm |
EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
 Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|
0-120-0018 |
Biologics |
25 mm |
EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
 Titanium Cup Tip, 250 ml |
|
0-120-0019 |
Biologics |
250 ml |
EUR 1377 |
|
Description: includes Interface Washers |
) Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|
0-120-0021 |
Biologics |
each |
EUR 113 |
|
Description: includes Interface Washers |
 Continuous Flow Chamber |
|
0-120-0026 |
Biologics |
each |
EUR 774 |
|
Description: includes Interface Washers |
 Interface Washers 1.5” Diameter, 5/Pkg |
|
0-120-003 |
Biologics |
1.5'' Diameter |
EUR 31 |
 13 mm Diameter Solid Titanium Extender Tip |
|
0-120-0032 |
Biologics |
13 mm |
EUR 301 |
 13 mm Diameter Tapped Titanium Extender Tip |
|
0-120-0033 |
Biologics |
13 mm |
EUR 362 |
 19 mm Diameter Solid Titanium Extender Tip |
|
0-120-0034 |
Biologics |
19 mm |
EUR 315 |
 19 mm Diameter Tapped Titanium Extender Tip |
|
0-120-0035 |
Biologics |
19 mm |
EUR 375 |
 25 mm Diameter Solid Titanium Extender Tip |
|
0-120-0036 |
Biologics |
25 mm |
EUR 328 |
 25 mm Diameter Tapped Titanium Extender Tip |
|
0-120-0037 |
Biologics |
25 mm |
EUR 389 |
 KoldPod, 1.5ml Micro Tube |
|
0-120-0038 |
Biologics |
1.5 ml |
EUR 152 |
|
Description: Thermo conductive tube pods |
 KoldPod, 15ml Conical Tube |
|
0-120-0039 |
Biologics |
15 ml |
EUR 275 |
|
Description: Thermo conductive tube pods |
 KoldPod, 50ml Conical Tube |
|
0-120-0040 |
Biologics |
50 ml |
EUR 290 |
|
Description: Thermo conductive tube pods |
 Model 150 V/T Ultrasonic Homogenizer |
|
0-121-0002 |
Biologics |
210-240V/50-60Hz |
EUR 2920 |
|
|
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
 Model 300 V/T Ultrasonic Homogenizer |
|
0-122-0002 |
Biologics |
210-240V/50-60Hz |
EUR 3520 |
|
|
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
 SONABOZ Sound Abating Chamber |
|
0-125-0001 |
Biologics |
each |
EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
 Model 3000 Ultrasonic Homogenizer |
|
0-127-0002 |
Biologics |
210-240V/50-60Hz |
EUR 4120 |
|
|
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
 Model 3000MP Ultrasonic Homogenizer |
|
0-128-0002 |
Biologics |
210-240V/50-60Hz |
EUR 4720 |
|
|
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
 OMNICON® Zone Reader, 210-240V/50-60Hz |
|
0-131-0002 |
Biologics |
210-240V/50-60Hz |
EUR 35200 |
|
|
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
 OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|
0-134-0002 |
Biologics |
210-240V/50-60Hz |
EUR 32200 |
|
|
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
 Peni Cylinder Dispenser with Manual Hopper |
|
0-144-0002 |
Biologics |
each |
EUR 5406 |
|
|
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
 Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|
0-144-0003 |
Biologics |
100-240V/50-60Hz |
EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
 Stainless Steel Peni Cylinder with Flat Face |
|
0-144-0005 |
Biologics |
6mm I.D. x 8mm O.D. x 10mm Long |
EUR 399 |
|
Description: sold in packages of 100 pieces |
 Stainless Steel Peni Cylinder with Chamfered Face |
|
0-144-0006 |
Biologics |
6mm I.D. x 8mm O.D. x 10mm Long |
EUR 412 |
|
Description: sold in packages of 100 pieces |
) Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|
000-CUS |
Alpha Diagnostics |
Custom |
EUR 602 |
 Alpha-Bungarotoxin, CF®405S, 500 ug |
|
00002 |
Biotium |
1UG |
EUR 527 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-bungarotoxin, CF405s |
|
00002 |
Cusabio |
500uG |
EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|
00002-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®405S 100ug |
|
00002-100ug |
Biotium |
100uG |
EUR 132 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®680R, 500 ug |
|
9-00003 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®680R, 500 ug |
|
00003-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®680R 100ug |
|
9-00003 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®640R, 500 ug |
|
9-00004 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®640R, 500 ug |
|
00004-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®640R 100ug |
|
9-00004 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®488A, 500 ug |
|
9-00005 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®488A, 500 ug |
|
00005-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin CF®488A 100ug |
|
9-00005 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®568, 500 ug |
|
9-00006 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®568, 500 ug |
|
00006-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®568 100ug |
|
9-00006 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®594, 500 ug |
|
9-00007 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®594, 500 ug |
|
00007-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin CF®594 100ug |
|
9-00007 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Alpha-Bungarotoxin, CF®633, 500 ug |
|
9-00009 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®633, 500 ug |
|
00009-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®633 100ug |
|
9-00009 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|
0001-PP-001 |
IBT Bioservices |
1 cell line (can order x amount) |
EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
 Alpha-Bungarotoxin, 1 mg |
|
00010-1 |
Biotium |
1MG |
EUR 193 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, 1 mg |
|
00010-1-1 |
Biotium |
EA |
EUR 193 |
 Fluorescein-Alpha-Bungarotoxin, 500 ug |
|
00011 |
Biotium |
500uG |
EUR 376 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|
00011-1 |
Biotium |
EA |
EUR 376 |
 Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|
00012 |
Biotium |
500uG |
EUR 394 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|
00012-1 |
Biotium |
EA |
EUR 394 |
 Fluorescein-alpha-bungarotoxin, 10x50ug |
|
00013 |
Biotium |
10ST |
EUR 436 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|
00013-1 |
Biotium |
EA |
EUR 436 |
 Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|
00014 |
Biotium |
10ST |
EUR 494 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|
00014-1 |
Biotium |
EA |
EUR 494 |
 Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|
00015 |
Biotium |
500uG |
EUR 494 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|
00015-1 |
Biotium |
EA |
EUR 494 |
 Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|
00016 |
Biotium |
10ST |
EUR 560 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|
00016-1 |
Biotium |
EA |
EUR 560 |
 Biotin-XX-A-Bungarotoxin, 500 ug |
|
00017 |
Biotium |
500uG |
EUR 455 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Biotin-XX-A-Bungarotoxin, 500 ug |
|
00017-1 |
Biotium |
EA |
EUR 455 |
 Alpha-Bungarotoxin, CF®555, 500 ug |
|
9-00018 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®555, 500 ug |
|
00018-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®555 100ug |
|
9-00018 |
Biotium |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Biotin-cAMP, 1 mg |
|
00020 |
Biotium |
1MG |
EUR 298 |
|
|
|
Description: N/A |
Biotin-cAMP, 1 mg |
|
00020-1 |
Biotium |
20ST |
EUR 298 |
|
|
|
Description: N/A |
 Biotin-cAMP, 50 ug |
|
00020-1-1 |
Biotium |
EA |
EUR 414 |
 Biotin-cGMP, 1 mg |
|
00021 |
Biotium |
1MG |
EUR 331 |
|
|
|
Description: N/A |
Biotin-cGMP, 1 mg |
|
00021-1 |
Biotium |
20ST |
EUR 331 |
|
|
|
Description: N/A |
 Biotin-cGMP, 20x50 ug |
|
00021-1-1 |
Biotium |
EA |
EUR 447 |
 Cyanine 644-cAMP, 1 mg |
|
00022 |
Biotium |
1MG |
EUR 496 |
|
|
|
Description: N/A |
Cyanine 644-cAMP, 1 mg |
|
00022-1 |
Biotium |
20ST |
EUR 496 |
|
|
|
Description: N/A |
 Cyanine 644-cAMP, 20x50 ug |
|
00022-1-1 |
Biotium |
EA |
EUR 647 |
 Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|
00023 |
Biotium |
1MG |
EUR 285 |
|
|
|
Description: N/A |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|
00023-1 |
Biotium |
EA |
EUR 285 |
 Staurosporine |
|
00025 |
Biotium |
100uG |
EUR 100 |
|
|
|
Description: N/A |
Staurosporine |
|
00025-1 |
Biotium |
EA |
EUR 100 |
 Alpha-Bungarotoxin, CF®543, 500 ug |
|
00026 |
Biotium |
500uG |
EUR 527 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®543, 500 ug |
|
00026-1 |
Biotium |
EA |
EUR 527 |
 Alpha-Bungarotoxin, CF®543, 100 ug |
|
00026-100ug |
Biotium |
1UG |
EUR 132 |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
 Rhodamine Phalloidin 300U |
|
00027 |
Biotium |
300 |
EUR 364 |
|
|
|
Description: N/A |
Rhodamine Phalloidin 300U |
|
00027-1 |
Biotium |
EA |
EUR 364 |
 Biotin-XX-Phalloidin |
|
00028 |
Biotium |
100U |
EUR 466 |
|
|
|
Description: N/A |
Biotin-XX-Phalloidin |
|
00028-1 |
Biotium |
EA |
EUR 466 |
 Fluorescein-Phalloidin |
|
00030 |
Biotium |
300U |
EUR 364 |
|
|
|
Description: N/A |
Fluorescein-Phalloidin |
|
00030-1 |
Biotium |
EA |
EUR 364 |
 Rhodamine 110 Phalloidin |
|
00032 |
Biotium |
300ST |
EUR 364 |
|
|
|
Description: N/A |
Rhodamine 110 Phalloidin |
|
00032-1 |
Biotium |
EA |
EUR 364 |
 Phalloidin) Sulforhodamine 101 (Texas Red®) Phalloidin |
|
00033 |
Biotium |
300EU |
EUR 364 |
|
|
|
Description: N/A |
Sulforhodamine 101 (Texas Red®) Phalloidin |
|
00033-1 |
Biotium |
EA |
EUR 364 |
 Phalloidin, CF®405M |
|
00034 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®405M |
|
00034-1 |
Biotium |
EA |
EUR 482 |
Phalloidin, CF®405M |
|
00034-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®405M |
|
00034-T-1 |
Biotium |
EA |
EUR 101 |
 CF®488A-cAMP |
|
00036 |
Biotium |
100ug |
EUR 136 |
|
|
|
Description: N/A |
CF®488A-cAMP |
|
00036-1 |
Biotium |
EA |
EUR 136 |
 CF®640R-cAMP |
|
00037 |
Biotium |
100ug |
EUR 136 |
|
|
|
Description: N/A |
CF®640R-cAMP |
|
00037-1 |
Biotium |
EA |
EUR 136 |
 Phalloidin, CF555 |
|
00040 |
Biotium |
300U |
EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF555 |
|
00040-T |
Biotium |
50U |
EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
 Phalloidin, CF®647, 300 U |
|
00041 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®647, 300 U |
|
00041-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®647, 50 U |
|
00041-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®647, 50 U |
|
00041-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®488A, 300 U |
|
00042 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®488A, 300 U |
|
00042-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®488A, 50 U |
|
00042-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®488A, 50 U |
|
00042-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®543, 300 U |
|
00043 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®543, 300 U |
|
00043-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®543, 50 U |
|
00043-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®543, 50 U |
|
00043-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®568, 300 U |
|
00044 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®568, 300 U |
|
00044-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®568, 50 U |
|
00044-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®568, 50 U |
|
00044-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®594, 300 U |
|
00045 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®594, 300 U |
|
00045-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®594, 50 U |
|
00045-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®594, 50 U |
|
00045-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®633, 300 U |
|
00046 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®633, 300 U |
|
00046-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®633, 50 U |
|
00046-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®633, 50 U |
|
00046-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®660R, 300 U |
|
00047 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®660R, 300 U |
|
00047-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®660R, 50 U |
|
00047-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®660R, 50 U |
|
00047-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®680R, 300 U |
|
00048 |
Biotium |
300U |
EUR 513 |
|
|
|
Description: N/A |
Phalloidin, CF®680R, 300 U |
|
00048-1 |
Biotium |
EA |
EUR 513 |
 Phalloidin, CF®680R, 50 U |
|
00048-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®680R, 50 U |
|
00048-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®350, 300 U |
|
00049 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®350, 300 U |
|
00049-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®350, 50 U |
|
00049-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®350, 50 U |
|
00049-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®640R, 300 U |
|
00050 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®640R, 300 U |
|
00050-1 |
Biotium |
EA |
EUR 482 |
 Phalloidin, CF®640R, 50 U |
|
00050-T |
Biotium |
50U |
EUR 101 |
|
|
|
Description: N/A |
Phalloidin, CF®640R, 50 U |
|
00050-T-1 |
Biotium |
EA |
EUR 101 |
 Phalloidin, CF®532, 300 U |
|
00051 |
Biotium |
300U |
EUR 482 |
|
|
|
Description: N/A |
Phalloidin, CF®532, 300 U |
|
00051-1 |
Biotium |
EA |
EUR 482 |
Amongst these, 215 DEGs had been upregulated and 242 DEGs had been downregulated within the acute injured samples in contrast with unhurt samples. The GO enrichment evaluation indicated that these DEGs had been primarily concerned in transport, the oxidation-reduction course of, the metabolic course of, steel ion binding, hydrolase exercise, and oxidoreductase exercise. The KEGG evaluation revealed that these DEGs had been considerably enriched within the PI3K-Akt signaling pathway, protein digestion and absorption pathway, and focal adhesion pathway. The hub genes together with Hnf4α, Pck1 and Timp1 had been validated by the qRT-PCR assay in NRK-49F cells within the H/R mannequin.
